Overview of lymphoma diagnosis in Brazilian public health system patients: Open data analysis for health care planning

• Published in: Hematology, Transfusion and Cell Therapy Transfusion and Cell Therapy, 2022-01, Vol.44 (1), p.40-48
• Main Authors: Martins, Denise Pires, Correa-Netto, Nelson Francisco, Melo, Nina, Loggetto, Sandra Regina, de Liberal, Marcia Mello Costa
• Format: Article
• Language: English
• Subjects: Delayed diagnosis; Lymphoma; MEDICINE, GENERAL & INTERNAL; Mortality; Neoplasm staging; Neoplasms; Original
• ISSN: 2531-1379; 2531-1387; 2531-1387
• DOI: 10.1016/j.htct.2020.08.017

Knowing the information regarding the panorama of lymphoma diagnosis in patients treated in the Brazilian Public Unified Health System from the last 10 years is a challenge for Strategic Health Planning. To characterize the Brazilian population with lymphoma treated in the Brazilian Public Unified Health System between 2008 and 2017 regarding staging, sex, residence site and mortality. A descriptive, retrospective, and longitudinal trial with secondary data from DataSUS (SIA/SUS and SIM/SUS) obtained from patients with ICD-10 C81-85. There were 70,850 lymphoma cases between 2008 and 2017, of which 55% were male, the median age was 51 years, and 27% had Hodgkin Lymphoma. Most patients (56%) were treated outside the residence city. São Paulo State accounted for 25% of patients. Treatment initiation took more than 60 days in 27% of cases. A total of 45,601 deaths were due to lymphoma (12% Hodgkin Lymphoma and 88% Non-Hodgkin Lymphoma), with a median age 63 years, and were mainly males (55%). Staging data were inadequate in 23% of patients, and analysis was performed only on the valid records. Advanced disease was diagnosed in 58% of patients (60% male; 57% female) and was more common in Non-Hodgkin Lymphoma (62%) versus Hodgkin Lymphoma (49%). Late diagnosis interferes with mortality rates. Health promotion and cancer prevention campaigns, especially targeting the male public, and training for early diagnosis and early treatment are needed. Effective measures for early diagnosis and treatment are urgently needed for lymphoma control.